Skip to main content
. 2022 Dec 23;15(1):106. doi: 10.3390/cancers15010106
3D-CRT 3-dimensional conformal radiotherapy
AC Adenocarcinoma
Carb/TAX Carboplatin and paclitaxel
dCRT Definite chemoradiation therapy
EC Esophageal cancer
GTV Gross target volume
Gy Gray
IMRT Intensity-modulated radiotherapy
nCRT Neoadjuvant chemoradiation therapy
OS Overall survival
PET/CT Positron emission tomography/computed tomography
PFS Progression-free survival
PTV Planning target volume
SCC Squamous cell carcinoma
QOL Quality of life